1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Innovative Small Molecule Targeted Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Innovative Small Molecule Targeted Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Innovative Small Molecule Targeted Drugs by Country/Region, 2018, 2022 & 2029
2.2 Innovative Small Molecule Targeted Drugs Segment by Type
2.2.1 Kinase Inhibitors
2.2.2 Epigenetic Inhibitors
2.2.3 Proteasome Inhibitor
2.3 Innovative Small Molecule Targeted Drugs Sales by Type
2.3.1 Global Innovative Small Molecule Targeted Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Innovative Small Molecule Targeted Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Innovative Small Molecule Targeted Drugs Sale Price by Type (2018-2023)
2.4 Innovative Small Molecule Targeted Drugs Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Innovative Small Molecule Targeted Drugs Sales by Application
2.5.1 Global Innovative Small Molecule Targeted Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Innovative Small Molecule Targeted Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Innovative Small Molecule Targeted Drugs Sale Price by Application (2018-2023)
3 Global Innovative Small Molecule Targeted Drugs by Company
3.1 Global Innovative Small Molecule Targeted Drugs Breakdown Data by Company
3.1.1 Global Innovative Small Molecule Targeted Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Innovative Small Molecule Targeted Drugs Sales Market Share by Company (2018-2023)
3.2 Global Innovative Small Molecule Targeted Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Innovative Small Molecule Targeted Drugs Revenue by Company (2018-2023)
3.2.2 Global Innovative Small Molecule Targeted Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Innovative Small Molecule Targeted Drugs Sale Price by Company
3.4 Key Manufacturers Innovative Small Molecule Targeted Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Innovative Small Molecule Targeted Drugs Product Location Distribution
3.4.2 Players Innovative Small Molecule Targeted Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Innovative Small Molecule Targeted Drugs by Geographic Region
4.1 World Historic Innovative Small Molecule Targeted Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Innovative Small Molecule Targeted Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Innovative Small Molecule Targeted Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Innovative Small Molecule Targeted Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Innovative Small Molecule Targeted Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Innovative Small Molecule Targeted Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Innovative Small Molecule Targeted Drugs Sales Growth
4.4 APAC Innovative Small Molecule Targeted Drugs Sales Growth
4.5 Europe Innovative Small Molecule Targeted Drugs Sales Growth
4.6 Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Growth
5 Americas
5.1 Americas Innovative Small Molecule Targeted Drugs Sales by Country
5.1.1 Americas Innovative Small Molecule Targeted Drugs Sales by Country (2018-2023)
5.1.2 Americas Innovative Small Molecule Targeted Drugs Revenue by Country (2018-2023)
5.2 Americas Innovative Small Molecule Targeted Drugs Sales by Type
5.3 Americas Innovative Small Molecule Targeted Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Innovative Small Molecule Targeted Drugs Sales by Region
6.1.1 APAC Innovative Small Molecule Targeted Drugs Sales by Region (2018-2023)
6.1.2 APAC Innovative Small Molecule Targeted Drugs Revenue by Region (2018-2023)
6.2 APAC Innovative Small Molecule Targeted Drugs Sales by Type
6.3 APAC Innovative Small Molecule Targeted Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Innovative Small Molecule Targeted Drugs by Country
7.1.1 Europe Innovative Small Molecule Targeted Drugs Sales by Country (2018-2023)
7.1.2 Europe Innovative Small Molecule Targeted Drugs Revenue by Country (2018-2023)
7.2 Europe Innovative Small Molecule Targeted Drugs Sales by Type
7.3 Europe Innovative Small Molecule Targeted Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Innovative Small Molecule Targeted Drugs by Country
8.1.1 Middle East & Africa Innovative Small Molecule Targeted Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Innovative Small Molecule Targeted Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Innovative Small Molecule Targeted Drugs Sales by Type
8.3 Middle East & Africa Innovative Small Molecule Targeted Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Innovative Small Molecule Targeted Drugs
10.3 Manufacturing Process Analysis of Innovative Small Molecule Targeted Drugs
10.4 Industry Chain Structure of Innovative Small Molecule Targeted Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Innovative Small Molecule Targeted Drugs Distributors
11.3 Innovative Small Molecule Targeted Drugs Customer
12 World Forecast Review for Innovative Small Molecule Targeted Drugs by Geographic Region
12.1 Global Innovative Small Molecule Targeted Drugs Market Size Forecast by Region
12.1.1 Global Innovative Small Molecule Targeted Drugs Forecast by Region (2024-2029)
12.1.2 Global Innovative Small Molecule Targeted Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Innovative Small Molecule Targeted Drugs Forecast by Type
12.7 Global Innovative Small Molecule Targeted Drugs Forecast by Application
13 Key Players Analysis
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Innovative Small Molecule Targeted Drugs Product Portfolios and Specifications
13.1.3 Roche Innovative Small Molecule Targeted Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Innovative Small Molecule Targeted Drugs Product Portfolios and Specifications
13.2.3 Pfizer Innovative Small Molecule Targeted Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Genetech
13.3.1 Genetech Company Information
13.3.2 Genetech Innovative Small Molecule Targeted Drugs Product Portfolios and Specifications
13.3.3 Genetech Innovative Small Molecule Targeted Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Genetech Main Business Overview
13.3.5 Genetech Latest Developments
13.4 Novartis
13.4.1 Novartis Company Information
13.4.2 Novartis Innovative Small Molecule Targeted Drugs Product Portfolios and Specifications
13.4.3 Novartis Innovative Small Molecule Targeted Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Novartis Main Business Overview
13.4.5 Novartis Latest Developments
13.5 Bayer
13.5.1 Bayer Company Information
13.5.2 Bayer Innovative Small Molecule Targeted Drugs Product Portfolios and Specifications
13.5.3 Bayer Innovative Small Molecule Targeted Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Bayer Main Business Overview
13.5.5 Bayer Latest Developments
13.6 Abbive
13.6.1 Abbive Company Information
13.6.2 Abbive Innovative Small Molecule Targeted Drugs Product Portfolios and Specifications
13.6.3 Abbive Innovative Small Molecule Targeted Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Abbive Main Business Overview
13.6.5 Abbive Latest Developments
13.7 Jiangsu Hengrui Pharmaceuticals
13.7.1 Jiangsu Hengrui Pharmaceuticals Company Information
13.7.2 Jiangsu Hengrui Pharmaceuticals Innovative Small Molecule Targeted Drugs Product Portfolios and Specifications
13.7.3 Jiangsu Hengrui Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Jiangsu Hengrui Pharmaceuticals Main Business Overview
13.7.5 Jiangsu Hengrui Pharmaceuticals Latest Developments
13.8 Jiangsu Chia Tai-Tianqing Pharmaceutical
13.8.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Company Information
13.8.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Innovative Small Molecule Targeted Drugs Product Portfolios and Specifications
13.8.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Innovative Small Molecule Targeted Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Main Business Overview
13.8.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Latest Developments
13.9 QILU Pharmaceutical
13.9.1 QILU Pharmaceutical Company Information
13.9.2 QILU Pharmaceutical Innovative Small Molecule Targeted Drugs Product Portfolios and Specifications
13.9.3 QILU Pharmaceutical Innovative Small Molecule Targeted Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 QILU Pharmaceutical Main Business Overview
13.9.5 QILU Pharmaceutical Latest Developments
13.10 Betta Pharmaceuticals
13.10.1 Betta Pharmaceuticals Company Information
13.10.2 Betta Pharmaceuticals Innovative Small Molecule Targeted Drugs Product Portfolios and Specifications
13.10.3 Betta Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Betta Pharmaceuticals Main Business Overview
13.10.5 Betta Pharmaceuticals Latest Developments
13.11 Shanghai Junshi Biosciences
13.11.1 Shanghai Junshi Biosciences Company Information
13.11.2 Shanghai Junshi Biosciences Innovative Small Molecule Targeted Drugs Product Portfolios and Specifications
13.11.3 Shanghai Junshi Biosciences Innovative Small Molecule Targeted Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Shanghai Junshi Biosciences Main Business Overview
13.11.5 Shanghai Junshi Biosciences Latest Developments
13.12 Shanghai Allist Pharmaceuticals
13.12.1 Shanghai Allist Pharmaceuticals Company Information
13.12.2 Shanghai Allist Pharmaceuticals Innovative Small Molecule Targeted Drugs Product Portfolios and Specifications
13.12.3 Shanghai Allist Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Shanghai Allist Pharmaceuticals Main Business Overview
13.12.5 Shanghai Allist Pharmaceuticals Latest Developments
13.13 Shenzhen Chipscreen Biosciences
13.13.1 Shenzhen Chipscreen Biosciences Company Information
13.13.2 Shenzhen Chipscreen Biosciences Innovative Small Molecule Targeted Drugs Product Portfolios and Specifications
13.13.3 Shenzhen Chipscreen Biosciences Innovative Small Molecule Targeted Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Shenzhen Chipscreen Biosciences Main Business Overview
13.13.5 Shenzhen Chipscreen Biosciences Latest Developments
13.14 Innovent Biologics, Inc.
13.14.1 Innovent Biologics, Inc. Company Information
13.14.2 Innovent Biologics, Inc. Innovative Small Molecule Targeted Drugs Product Portfolios and Specifications
13.14.3 Innovent Biologics, Inc. Innovative Small Molecule Targeted Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Innovent Biologics, Inc. Main Business Overview
13.14.5 Innovent Biologics, Inc. Latest Developments
13.15 Hinova Pharmaceuticals
13.15.1 Hinova Pharmaceuticals Company Information
13.15.2 Hinova Pharmaceuticals Innovative Small Molecule Targeted Drugs Product Portfolios and Specifications
13.15.3 Hinova Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Hinova Pharmaceuticals Main Business Overview
13.15.5 Hinova Pharmaceuticals Latest Developments
14 Research Findings and Conclusion
※参考情報 革新的低分子標的薬は、癌や自己免疫疾患、感染症などの病気に対して高い治療効果を示すために開発された、分子量が小さい薬剤を指します。これらの薬剤は、特定の生物学的マーカーや病変に対して選択的に作用するため、従来の治療方法に比べて副作用が少ないことが特徴です。近年、低分子標的薬は新しい治療戦略として注目を集めており、その革新性と可能性は非常に高いと言えます。 まず、革新的低分子標的薬の定義について述べます。低分子標的薬とは、分子量が通常500ダルトン以下の化合物であり、特定のタンパク質や遺伝子の機能を直接的に調節する作用を持っています。これにより、異常を示す細胞の増殖や生存を抑制することができます。革新性は、これらの薬剤が新たな作用機序やターゲティング戦略を採用している点にあります。 次に、特徴について説明します。低分子標的薬は、主に次のような特徴を持っています。第一に、特異性です。これらの薬剤は、特定の病態に関与する分子をターゲットにすることで、正常細胞に対する影響を最小限に抑えることができます。第二に、経口投与が可能な場合が多いことも挙げられます。注射ではなく、経口で服用できることは患者のQOL(生活の質)向上に寄与します。第三に、迅速な作用発現です。低分子薬は組織や細胞に迅速に浸透し、短期間で効果を発揮することが可能です。 革新的低分子標的薬の種類については、以下のように分類されます。まず、酵素阻害剤が挙げられます。これにはキナーゼ阻害剤が多く含まれ、がん細胞の信号伝達を遮断することで、細胞の増殖を抑制します。次に、受容体拮抗剤があり、特定の受容体に結合することでその機能を阻害します。さらに、転写因子や他の細胞内分子をターゲットにした薬剤も開発されています。これらの薬剤は、市販されているものから開発段階にあるものまで多岐にわたります。 用途としては、主に癌治療において多くの新しい低分子標的薬が承認されています。例えば、慢性骨髄性白血病に対するイマチニブ(Gleevec)や、非小細胞肺癌に対するエルロチニブ(Tarceva)などが挙げられます。これらの薬剤は、特定の遺伝子変異や異常が関与する腫瘍に対して効果を示すことから、個別化医療の一環としての重要性が高まっています。また、免疫疾患や感染症に対する新しい戦略も進行中であり、治療が難しい疾患に対しても貢献が期待されています。 関連技術についても触れておくべきでしょう。まず、薬剤設計の段階でコンピュータ支援設計(CADD)が用いられることが多く、これにより化合物の候補を迅速に見出すことが可能になっています。また、合成化学の進展によって、多様な化合物ライブラリーの構築が可能となり、スクリーニングを通じて新たな低分子薬の発見が加速しています。さらに、バイオマーカー研究も重要な技術であり、特定の標的への適応や予後の予測を行う手助けをします。これにより、患者により適切な治療法を選定する基盤が形成されます。 最終的に、革新的低分子標的薬は、今後の医療においてますます重要なだけでなく、より多くの病気に対する新しい治療法の開発が期待されます。この流れの中で、研究者や企業は、新しい標的の発見や作用機序の解明を追求し続けなければなりません。また、臨床試験のデザインや医療環境での適用に関しても、革新的なアプローチが求められています。 このように、革新的低分子標的薬は、がん治療を中心に多様な分野での応用が期待されている新しい治療法の一つです。その特異性、効果、経口投与可能性などの特徴から、多くの患者にとって重要な治療選択肢となってきています。今後もこの分野の進展が注目され、私たちの医療の未来に大きな影響を与えることが期待されます。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/